Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2.Hsiao‐Fan Chen, Mien‐Chie Hung, Po‐Ren Hsueh et al.|PubMed|2022Cited by 19
Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasionDongli Linghu, Linlin Sun, Jiaming Song et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 13
Anti-Sars-Cov-2 and Anticancer Properties of Triptolide and its Derived Carbonized NanomaterialsTahira Akhtar, Li X, Bbumba Patrick et al.|SSRN Electronic Journal|2024Cited by 0
Galectin-9-driven immune evasion constrains radiotherapy-induced systemic antitumor immunityJiaming Song, Linlin Sun, Boning Liu et al.|Journal for ImmunoTherapy of Cancer|2026Cited by 0